References

1.

Watson, WA, Litovitz, TL, Rodgers, GC et al. The 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589.

2.

Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings Office of Applied Studies, NSDUH Series H-28, DHHS Publication No. SMA 05-4062, Rockville, MD 2005.

3.

Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-28, DHHS Publication No. (SMA) 06-4143, Rockville, MD 2006.

4.

Waldhoer, M, Bartlett, SE, Whistler, JL. Opioid receptors. Annu Rev Biochem 2004; 73:953.

5.

Bonci, A, Bernardi, G, Grillner, P, Mercuri, NB. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?. Trends Pharmacol Sci 2003; 24:172.

6.

Aghajanian, GK, Wang, YY. Common alpha 2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 1987; 26:793.

7.

Davies, G, Kingswood, C, Street, M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 1996; 31:410.

8.

Darke, S, Zador, D. Fatal heroin 'overdose': a review. Addiction 1996; 91:1765.

9.

Ghoneim, MM, Dhanaraj, J, Choi, WW. Comparison of four opioid analgesics as supplements to nitrous oxide anesthesia. Anesth Analg 1984; 63:405.

10.

Hoffman, JR, Schriger, DL, Luo, JS. The empiric use of naloxone in patients with altered mental status: A reappraisal. Ann Emerg Med 1991; 20:246.

11.

Fahmy, NR, Sunder, N, Soter, NA. Role of histamine in the hemodynamic and plasma catecholamine responses to morphine. Clin Pharmacol Ther 1983; 33:615.

12.

Ashbourne, JF, Olson, KR, Khayam-Bashi, H. Ann Emerg Med 1989; 18:1035.

13.

Stork, CM, Redd, JT, Fine, K, Hoffman, RS. Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate--a case report. J Toxicol Clin Toxicol 1995; 33:179.

14.

Krantz, MJ, Kutinsky, IB, Robertson, AD, Mehler, PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 2003; 23:802.

15.

Mills, CA, Flacke, JW, Flacke, WE, et al. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Can J Anaesth 1990; 37:238.

16.

Berlot, G, Gullo, A, Romano, E, Rinaldi, A. Naloxone in cardiorespiratory arrest. Anaesthesia 1985; 40:819.

17.

Bertini, G, Russo, L, Cricelli, F, et al. Role of a prehospital medical system in reducing heroin-related deaths. Crit Care Med 1992; 20:493.

18.

Osterwalder, JJ. Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996; 34:409.

19.

Goldfrank, L, Weisman, RS, Errick, JK, Lo, MW. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med 1986; 15:566.

20.

Gill, JR. Ten years of "body packers" in New York City: 50 deaths. J Forensic Sci 2002; 47:843.

21.

Traub, SJ, Hoffman, RS, Nelson, LS. Body packing- The internal concealment of illicit drugs. N Engl J Med 2003; 349:2519.

22.

Duberstein, JL, Kaufman, DM. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med 1971; 51:704.

23.

Osler, W: Oedema of the left lung—morphia poisoning. Montreal General Hospital Reports Clinical and Pathological, vol 1. Montreal, Dawson Bros Publishers, 1880. p. 291.

24.

Frand, UI, Shim, CS, Williams, MH Jr. Methadone-induced pulmonary edema. Ann Intern Med 1972; 76:975.